Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06522919 |
| Title | Sequential Immunochemotherapy Treatment With Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer (CombiCoR-Vax) |
| Acronym | CombiCoR-Vax |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l. | Meldola | Forlì Cesena | 47014 | Italy | Details | |
| Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card.G.Panico" | Tricase | Lecce | 73039 | Italy | Details |